IQVIA Q2 Earnings Beat Estimates as R&DS Bookings Rise 19%

Zacks Investment Research··US·Read original
3▲1 ▼0Impact / 5
Summary · why it matters

IQVIA Holdings reported second-quarter 2026 adjusted earnings of $3.15 per share, up 12.1% year over year and beating the Zacks Consensus Estimate of $3.02 by 4.3%, while revenues of $4.37 billion rose 8.7% and topped the consensus mark of $4.29 billion by 1.6%. In the quarter, Research & Development Solutions net new bookings increased 19% year over year to $3.2 billion, and trailing-12-month bookings escalated 13% to $11.3 billion. The company repurchased $398 million of shares in the second quarter, part of $950 million bought back in the first half of 2026, leaving $2.8 billion of authorization as of June 30, 2026. Operating cash flow rose 26% year over year to $558 million and free cash flow increased 23.3% to $360 million, while net debt was $14.1 billion and net leverage stood at 3.6X adjusted EBITDA. IQVIA pays no cash dividends on its common stock, and peers Paychex and Fiserv also reported quarterly results.

Impact on assets 3

Biotech & Genomic Medicine▲ · 1 stocks
IQVIA Holdings Inc
IQV
▲ PositiveCapitalDemandrelevance

Q2 earnings and revenue beat estimates, with EPS up 12.1% and buybacks of $398M in the quarter.

Digital Finance & Tokenization▲ · 1 stocks
Cloud & Digital Infrastructure▲ · 1 stocks